June 25, 2018 | Katie Neith
In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.
Sound Therapy: TGen Tests Ultrasound to Enhance Cancer Drug Delivery
March 26, 2018 | City of Hope
City of Hope affiliate TGen has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.
Behnam Ebrahimi, M.D.: Leading-edge Care in Rancho Cucamonga
March 19, 2018 | Travis Marshall
As a medical oncologist at City of Hope’s Rancho Cucamonga location, Behnam Ebrahimi, M.D., treats a wide range of cancer types, and enjoys being part of a center renowned for its multidisciplinary care.
'Marley Team' seeks to develop early pancreatic cancer screening tools
January 9, 2018 | Stephanie Smith
A multi-institutional partnership, funded in part by a multimillion-dollar grant from the Kemper and Ethyl Marley Foundation, is designed to develop a “mammogram” for pancreatic cancer.
Striding toward a cure for pancreatic cancer
May 3, 2016 | City of Hope
City of Hope will be participating in PanCan’s annual PurpleStride event on May 7, a 5k walk/run at Exposition Park in Los Angeles. By participating, City of Hope and its team of runners, the City of Hope Striders, will help to raise much-needed awareness of this deadly disease.
Purging pancreatic cancer with bacteria-based immunotherapy
July 1, 2015 | Jyoti Madhusoodanan
City of Hope researchers have identified a promising new strategy: a bacterial-based therapy that homes to tumors and provokes an incredibly effective tumor-killing response. The outlook and length of survival has not changed much in the past 25 years for patients suffering from an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC).
Cancer 2015: Liver cancer expert offers view from the front lines
December 24, 2014 | Tami Dennis
Yuman Fong, M.D., is an internationally recognized expert in hepatobiliary cancer – that is liver cancer, pancreatic cancer, gallbladder cancer and cancer of the bile ducts. He's also renowned for his use of genetically modified viruses to combat malignant disease, is a pioneer in the operating room and the laboratory, is the author of more than 600 peer-reviewed articles and 11 textbooks, and is the chair of the Department of Surgery at City of Hope.
Meet our doctors: Yuman Fong on the future of cancer surgery
April 19, 2014 | Kim Proescholdt
Meet City of Hope’s new chair of the Department of Surgery – esteemed pancreatic and hepatobiliary surgeon, researcher and author Yuman Fong, M.D. As one of today’s most respected and recognizable physicians in the treatment of cancers of the liver, bile duct , gallbladder and pancreas , Fong has pioneered and enhanced many surgical therapies now widely used around the world to treat these difficult diseases.
Cancer treatment in 2014: Making the most of research
December 28, 2013 | Tami Dennis
Cancer will be defeated not in one enormous advance, experts agree, but in incremental advances. Those incremental advances often go unnoticed by the public at the time of their discovery, but in the years to come, they add up – to more life years, to greater survival rates, to more time spent with families and loved ones.
Pancreatic cancer: An exploration of leading surgical techniques
August 22, 2013 | Tami Dennis
Treatment of pancreatic cancer starts with surgery, when operable. And though the overall statistics are often grim, newer treatment algorithms continue to evolve with the ultimate aim of beating this cancer.
Could two targeted therapies be a better solution for pancreatic cancer?
July 24, 2012 | Wayne Lewis
Imagine a familiar scenario straight out of your favorite scary movie. A relentless villain sets his sights on a bunch of carefree teens. As the terror mounts, they throw one obstacle after another in his path.